
Preclinical testing at The Ohio State University found Telomir-Zn inhibited growth of canine and human osteosarcoma cell lines, prompting the company to explore a possible in-vivo study in dogs with naturally occurring tumors.
Check out this week’s highlights
Happy Saturday dvm360 readers! We hope you are enjoying your weekend by taking time to relax and spend time with friends in family in the (hopefully) nice weather. While you sit back and relax, we are here to continue providing our readers with the latest news in veterinary medicine.
Here is what was hot this week on dvm360.com:





